Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients

被引:0
|
作者
Andrea Dalbeni
Alessandro Giollo
Michele Bevilacqua
Giovanni Cioffi
Angela Tagetti
Filippo Cattazzo
Giovanni Orsolini
Federica Ognibeni
Pietro Minuz
Maurizio Rossini
Cristiano Fava
Ombretta Viapiana
机构
[1] University and Azienda Ospedaliera Universitaria Integrata of Verona,Division of General Medicine and Hypertension, Department of Medicine
[2] University and Azienda Ospedaliera Universitaria Integrata of Verona,Division of Rheumatology, Department of Medicine
来源
Hypertension Research | 2020年 / 43卷
关键词
Traditional cardiovascular risk factors; Subclinical atherosclerosis; Rheumatoid arthritis; Residual disease activity;
D O I
暂无
中图分类号
学科分类号
摘要
Patients with rheumatoid arthritis (RA) have an increased incidence of cardiovascular events. Ultrasound examination of the carotid arteries can show the presence of plaques and detect the atherosclerotic subclinical process through the evaluation of intima-media thickness (cIMT) and carotid segmental distensibility (cCD). The aim of the present study was to identify which factors could independently influence the evolution of atherosclerosis (plaques, cIMT, and cCD) after 1 year of follow-up in a sample of patients with RA. A total of 137 patients with RA without previous cardiovascular (CV) events were enrolled at baseline, and 105 (M/F: 21/84, age 59.34 ± 11.65 years) were reassessed after one year using ultrasound of carotid arteries to detect atheromatous plaques and to measure cIMT and cCD. After one year, all the indices of subclinical atherosclerosis worsened with respect to baseline (Δ-cIMT = 0.030 ± 0.10 mm, p = 0.005; Δ-cCD = −1.64 ± 4.83, 10–3/KPa, p = 0.005; Δ-plaques = 8.6%, p = 0.035). Traditional CV risk factors (age, mean arterial pressure, and diabetes) and corticosteroid therapy were independently associated with the worsening of subclinical atherosclerosis. Interestingly, when considering RA patients divided according to the degree of disease activity score 28 with C-reactive protein (DAS28 [CRP] ≥2.6), the worsening of subclinical atherosclerosis indices was detectable exclusively in the group of patients with active disease. Our longitudinal study supports the hypothesis of a key role of both traditional CV risk factors and the inflammatory activity of arthritic disease in the progression of subclinical atherosclerosis in RA patients. In addition, corticosteroids might have a deleterious effect.
引用
收藏
页码:922 / 928
页数:6
相关论文
共 50 条
  • [1] Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients
    Dalbeni, Andrea
    Giollo, Alessandro
    Bevilacqua, Michele
    Cioffi, Giovanni
    Tagetti, Angela
    Cattazzo, Filippo
    Orsolini, Giovanni
    Ognibeni, Federica
    Minuz, Pietro
    Rossini, Maurizio
    Fava, Cristiano
    Viapiana, Ombretta
    HYPERTENSION RESEARCH, 2020, 43 (09) : 922 - 928
  • [2] Traditional and Nontraditional Cardiovascular Risk Factors Are Associated with Atherosclerosis in Rheumatoid Arthritis
    Dessein, Patrick H.
    Joffe, Barry I.
    Veller, Martin G.
    Stevens, Belinda A.
    Tobias, Milton
    Reddi, Kogie
    Stanwix, Anne E.
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (03) : 435 - 442
  • [3] Serum irisin level in rheumatoid arthritis patients: Relationship to disease activity, subclinical atherosclerosis, and cardiovascular risk factors
    Soliman, Samar A.
    Gad, Reem
    Senosy, Tarek
    Higazi, Aliaa M.
    Elshereef, Rawhya
    EGYPTIAN RHEUMATOLOGIST, 2022, 44 (02) : 109 - 114
  • [4] Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis
    Liao, Katherine P.
    Solomon, Daniel H.
    RHEUMATOLOGY, 2013, 52 (01) : 45 - 52
  • [5] Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis
    del Rincon, Inmaculada
    Polak, Joseph F.
    O'Leary, Daniel H.
    Battafarano, Daniel F.
    Erikson, John M.
    Restrepo, Jose F.
    Molina, Emily
    Escalante, Agustin
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1118 - 1123
  • [6] The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis
    Atul Deodhar
    Bojena Bitman
    Yue Yang
    David H Collier
    Clinical Rheumatology, 2016, 35 : 3045 - 3052
  • [7] The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis
    Deodhar, Atul
    Bitman, Bojena
    Yang, Yue
    Collier, David H.
    CLINICAL RHEUMATOLOGY, 2016, 35 (12) : 3045 - 3052
  • [8] Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients Without Traditional Cardiovascular Risk Factors
    Macias-Reyes, Hector
    Duran-Barragan, Sergio
    Cardenas-Contreras, Cynthia R.
    Chavez-Martin, Cesar G.
    Gomez-Banuelos, Eduardo
    Navarro-Hernandez, Rosa E.
    Yanowsky-Gonzalez, Carlos O.
    Gonzalez-Lopez, Laura
    Gamez-Nava, Jorge I.
    Vazquez-Del Mercado, Monica
    ARCHIVES OF RHEUMATOLOGY, 2016, 31 (03) : 208 - 214
  • [9] Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis
    Sattui, Sebastian E.
    Rajan, Mangala
    Lieber, Sarah B.
    Lui, Geyanne
    Sterling, Madeline
    Curtis, Jeffrey R.
    Mandl, Lisa A.
    Navarro-Millan, Iris
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (01) : 292 - 298
  • [10] CLINICAL ACTIVITY OF RHEUMATOID ARTHRITIS IS NOT ASSOCIATED WITH CARDIOVASCULAR RISK BY TRADITIONAL RISK SCALES
    Colunga-Pedraza, Iris J.
    Galarza-Delgado, DionicioA.
    Azpiri-Lopez, Joser.
    Beltran-Aguilar, Victor M.
    Gonzalez-Gonzalez, Valeria
    Arias-Peralta, Angel G.
    De Avila-Gonzalez, Natalia
    Cardenas-De la Garza, Jesus A.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S86 - S87